GeriatricNCT07562919
Comparison of Physical Performance, Balance, and Functional Mobility Parameters According to Walking Speed in Geriatric Individuals
An observational study of Geriatric and Elderly (People Aged 65 or More), run by Istanbul University - Cerrahpasa at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study is to examine the determining role of walking speed on physical performance parameters in individuals aged 65 and over. The study aims to compare flexibility, lower extremity muscle strength (5-count sit-stand test), static balance (single-leg balance), upper extremity muscle strength (hand… Read more about this study
- Who is it for?
- Ages 65 years and olderHealthy volunteers can take part
- Conditions the study is for
- Geriatric, Elderly (People Aged 65 or More)
- What is being tested?
- Assessments
- How many people
- 76 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 May 2026to 30 Aug 2026
- How long will I take part?
- 1 Week
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- Healthy volunteers accepted
- Older adult
Study population: Geriatric individuals aged 65 and over who meet the inclusion criteria for the study.
Who may be able to join
- Being 65 years of age or older
- Being able to perform walking functions
- Having sufficient mobility to perform the physical performance tests included in the research, such as 5 sit-stand tests, TUG (Trip and Go) tests, and stair climbing/descending tests. • Having a walking speed of at least 0.4 m/s or more as a result of the 4 Meter Walking Test (having limited or independent mobility within the community).
- Voluntarily agreeing to participate in the study and providing informed consent.
Who cannot join
- Having a history of advanced cognitive impairment or diagnosed dementia that would impair the ability to understand and follow test instructions.
- Those diagnosed with moderate or severe cognitive impairment (MMSE < 24 and/or MoCA < 21)
- Having a walking speed below 0.4 m/s on the 4-Meter Walk Test (individuals who are wheelchair-bound or bedridden).
- Advanced Parkinson's disease, active stroke sequelae, lower extremity fracture within the last 6 months, or a history of acute orthopedic surgery that primarily affects motor performance and balance.
- Those with severe hearing or vision loss
- Individuals experiencing significant difficulty communicating
- Participants who did not sign the voluntary consent form
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site
Balıkesir University
Balıkesir
GULFİDAN TOKGÖZ, Lecturer, PhD (c), 0552 022 76 32, gulfidan.tokgoz@gmail.com
Nilay ARMAN, Assoc. Prof. Dr., +905534558707
About this study
Official title: Comparison of Physical Performance, Balance, and Functional Mobility Parameters According to Walking Speed Threshold Values in Geriatric Individuals
The aim of this study is to examine the determining role of walking speed on physical performance parameters in individuals aged 65 and over. The study aims to compare flexibility, lower extremity muscle strength (5-count sit-stand test), static balance (single-leg balance), upper extremity muscle strength (hand grip), dynamic balance (FUT), functional mobility (TUG), and stair climbing/climbing skills in individuals with walking speeds of 0.4-0.8 m/s (limited community mobility) and above 0.8 m/s (independent community mobility).
Read the detailed description
Although the relationships between walking speed and individual physical parameters have been studied in the geriatric literature, comprehensive analyses comparing multidimensional parameters such as flexibility, static-dynamic balance, hand grip strength, and stair activity performance in groups separated according to walking speed threshold values (0.4-0.8 m/s and >0.8 m/s) are needed. This study aims to identify which physical components show the most significant deficits when walking speed decreases, thereby providing a scientific basis for clinical assessment processes and personalized preventive rehabilitation programs.
- Conditions
- Geriatric, Elderly (People Aged 65 or More)
- Being tested
- Assessments
- Keywords
- walkinp speed, physical fıtness, geriatric, elderly
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AssessmentsOther
Assessments will be conducted after obtaining voluntary consent from the participants. The physical performance tests to be applied within the scope of the research will be carried out by the research team within the framework of internationally accepted standard protocols whose validity and reliability have been proven in the geriatric population.
| Study group | Role | What they receive |
|---|---|---|
| Geriartric Indivıduals | Geriatric individuals aged 65 and over who meet the inclusion criteria for the study. Receives: Other: Assessments |
What is being measured
The primary outcome is the main question the study is designed to answer.
4-Meter Walk Test (Walking Speed Measurement)
Walking speed will be assessed using the 4-Meter Walk Test, a key indicator of functional mobility in geriatric individuals. Participants will be asked to walk a 4-meter test area in the center at their "natural and comfortable walking speed," using 1-meter "acceleration" zones at the beginning and 1-meter "deceleration" zones at the end of a 6-meter flat course. The measurement will be recorded with a stopwatch the moment the participant's foot crosses the 4-meter marked area, and the result will be calculated in m/s (Studenski et al., 2011).
Measured: 1 week
Secondary outcomes (7)
Time Sit-Stand Test (5STS):
To assess lower extremity muscle strength and balance, participants will be asked to stand up and sit down as quickly as possible, five times consecutively, from a standard chair 43-45 cm high, with their arms crossed over their chest. The timer will start with the "start" command and end when the fifth sitting is completed (Bohannon, 2006).
Measured: 1 week
Timed Up and Go (TUG):
To measure functional mobility, the participant will get up from the chair, walk a distance of 3 meters, return, and sit back down in the chair. This time will be recorded in seconds using a stopwatch (Podsiadlo \& Richardson, 1991).
Measured: 1 week
Functional Reach Test (FUT/FRT)
To measure static balance and stability limits, the maximum distance the participant can reach without losing balance and without taking a step, while standing next to a wall with the shoulder flexed at 90 degrees, will be measured (Duncan et al., 1990).
Measured: 1 week
Single Leg Balance Test (Right and Left):
Participants' static balance will be determined by recording the "time they can stand on one leg" (maximum 60 seconds) with their eyes open and hands on their hips, on both their dominant and non-dominant legs (Springer et al., 2007).
Measured: 1 week
Flexibility (Sit-and-Reach Test):
To measure hamstring and lower back flexibility, the participant will sit in a long, straight position, reaching forward without bending their knees. The distance reached by their fingertips will be recorded on a "sit-and-reach bench" (Wells \& Dillon, 1952).
Measured: 1 week
Stair Climbing Test
To assess high-level mobility, participants will be recorded in seconds for safely and as quickly as possible ascending and descending a staircase of standard step height [a specified number of steps, e.g., 10 steps] (Nightingale et al., 2003).
Measured: 1 week
Strength Measurement (Hand Grip Strength):
Upper extremity muscle strength will be measured using a digital hand dynamometer according to the ASHT (American Society of Hand Therapists) protocol. Participants will be asked to grip with maximum force while sitting upright, with shoulder adduction and elbow 90 degrees flexed. Three repetitions will be performed for each hand, and the average of these measurements in kilograms (kg) will be included in the analysis (Roberts et al., 2011; Cruz-Jentoft et al., 2019).
Measured: 1 week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 May 2026
- Study start1 May 2026 (estimated)
- Primary completion15 May 2026 (estimated)
- Study completion30 Aug 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for GeriatricStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 76 participants (estimated)
- Target duration
- 1 Week
Sponsor and investigators
- Lead sponsor
- Istanbul University - Cerrahpasa
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Gulfidan Tokgoz, Balikesir University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07562919
- Sponsor's protocol ID
- 2026/46
- Status last verified
- Apr 2026
- First submitted
- 25 Apr 2026
- Last updated
- 1 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Middleton A, Fritz SL, Lusardi M. Walking speed: the functional vital sign. J Aging Phys Act. 2015 Apr;23(2):314-22. doi: 10.1123/japa.2013-0236. Epub 2014 May 2.
PubMed 24812254Abellan van Kan G, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M, Cesari M, Donini LM, Gillette Guyonnet S, Inzitari M, Nourhashemi F, Onder G, Ritz P, Salva A, Visser M, Vellas B. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging. 2009 Dec;13(10):881-9. doi: 10.1007/s12603-009-0246-z.
PubMed 19924348
Study at a glance
From the registry record, last updated by the sponsor on 1 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Physical Performance, Balance, and Functional Mobility Parameters According to Walking Speed Threshold Values in Geriatric Individuals
- ClinicalTrials.gov ID
- NCT07562919
- Acronym / sponsor ID
- 2026/46
- Conditions
- Geriatric, Elderly (People Aged 65 or More)
- Keywords
- walkinp speed, physical fıtness, geriatric, elderly
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 76 participants (estimated)
- Lead sponsor
- Istanbul University - CerrahpasaUniversity, hospital or other
- Study start
- 1 May 2026 (estimated)
- Primary completion
- 15 May 2026 (estimated)
- Study completion
- 30 Aug 2026 (estimated)
- First posted
- 1 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to examine the determining role of walking speed on physical performance parameters in individuals aged 65 and over. The study aims to compare flexibility, lower extremity muscle strength (5-count sit-stand test), static balance (single-leg balance), upper extremity muscle strength (hand grip), dynamic balance (FUT), functional mobility (TUG), and stair climbing/climbing skills in individuals with walking speeds of 0.4-0.8 m/s (limited community mobility) and above 0.8 m/s (independent community mobility).
Detailed description
Although the relationships between walking speed and individual physical parameters have been studied in the geriatric literature, comprehensive analyses comparing multidimensional parameters such as flexibility, static-dynamic balance, hand grip strength, and stair activity performance in groups separated according to walking speed threshold values (0.4-0.8 m/s and >0.8 m/s) are needed. This study aims to identify which physical components show the most significant deficits when walking speed decreases, thereby providing a scientific basis for clinical assessment processes and personalized preventive rehabilitation programs.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Target follow-up
- 1 Week
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Geriartric Indivıduals | – | Other: AssessmentsGeriatric individuals aged 65 and over who meet the inclusion criteria for the study. |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
- Study population
- Geriatric individuals aged 65 and over who meet the inclusion criteria for the study.
Key inclusion criteria (4 listed)
- Being 65 years of age or older
- Being able to perform walking functions
- Having sufficient mobility to perform the physical performance tests included in the research, such as 5 sit-stand tests, TUG (Trip and Go) tests, and stair climbing/descending tests. • Having a walking speed of at least 0.4 m/s or more as a result of the 4 Meter Walking Test (having limited or independent mobility within the community).
- Voluntarily agreeing to participate in the study and providing informed consent.
Key exclusion criteria (7 listed)
- Having a history of advanced cognitive impairment or diagnosed dementia that would impair the ability to understand and follow test instructions.
- Those diagnosed with moderate or severe cognitive impairment (MMSE < 24 and/or MoCA < 21)
- Having a walking speed below 0.4 m/s on the 4-Meter Walk Test (individuals who are wheelchair-bound or bedridden).
- Advanced Parkinson's disease, active stroke sequelae, lower extremity fracture within the last 6 months, or a history of acute orthopedic surgery that primarily affects motor performance and balance.
- Those with severe hearing or vision loss
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AssessmentsAssessments will be conducted after obtaining voluntary consent from the participants. The physical performance tests to be applied within the scope of the research will be carried out by the research team within the framework of internationally accepted standard protocols whose validity and reliability have been proven in the geriatric population. | Other | Geriartric Indivıduals |
Primary outcome
4-Meter Walk Test (Walking Speed Measurement)
Time frame: 1 week
Walking speed will be assessed using the 4-Meter Walk Test, a key indicator of functional mobility in geriatric individuals. Participants will be asked to walk a 4-meter test area in the center at their "natural and comfortable walking speed," using 1-meter "acceleration" zones at the beginning and 1-meter "deceleration" zones at the end of a 6-meter flat course. The measurement will be recorded with a stopwatch the moment the participant's foot crosses the 4-meter marked area, and the result will be calculated in m/s (Studenski et al., 2011).
7 secondary outcomes
Time Sit-Stand Test (5STS):
Time frame: 1 week
Timed Up and Go (TUG):
Time frame: 1 week
Functional Reach Test (FUT/FRT)
Time frame: 1 week
Single Leg Balance Test (Right and Left):
Time frame: 1 week
Flexibility (Sit-and-Reach Test):
Time frame: 1 week
Stair Climbing Test
Time frame: 1 week
Strength Measurement (Hand Grip Strength):
Time frame: 1 week
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 May 2026.
- Results publication: PubMed 24812254Middleton A, Fritz SL, Lusardi M. Walking speed: the functional vital sign. J Aging Phys Act. 2015 Apr;23(2):314-22. doi: 10.1123/japa.2013-0236. Epub 2014 May 2.
- Results publication: PubMed 19924348Abellan van Kan G, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M, Cesari M, Donini LM, Gillette Guyonnet S, Inzitari M, Nourhashemi F, Onder G, Ritz P, Salva A, Visser M, Vellas B. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging. 2009 Dec;13(10):881-9. doi: 10.1007/s12603-009-0246-z.
- Individual participant dataSharing planned: No
Related trials for Geriatric
Active, not recruitingObservational study
Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy
NSCLC
Recruiting
Low Pneumoperitoneum Pressure for Delirium Prevention in Elderly Laparoscopy
Postoperative Delirium (POD), Intracranial Hypertension
RecruitingPhase 2
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
Diffuse Large B-Cell Lymphoma
Recruiting
Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
Suicide, Bereavement
Recruiting
Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery
Elderly, Cancer Surgery
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Geriatric and Elderly (People Aged 65 or More), run by Istanbul University - Cerrahpasa at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 1 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact GULFİDAN TOKGÖZ, Lecturer, PhD (c) (0552 022 76 32, gulfidan.tokgoz@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
4-Meter Walk Test (Walking Speed Measurement) (time frame: 1 week). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07562919, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2026.